In a patient with recurrent lower‑leg cellulitis who was previously treated with cefalexin (Keflex) and then clindamycin, should cefalexin be repeated?

Do Not Repeat Cefalexin (Keflex) for This Recurrent Cellulitis

In a patient with recurrent lower leg cellulitis who has already failed both cefalexin and clindamycin, repeating cefalexin is not recommended—you should investigate the underlying cause of recurrence, address predisposing factors, and consider either a different antibiotic class or long-term prophylaxis rather than simply cycling back to a previously failed agent.

Why Repeating Cefalexin Is Problematic

The fact that cellulitis has returned after two different antibiotic courses (cefalexin, then clindamycin) suggests either:

• Treatment failure due to resistant organisms (possibly MRSA or atypical pathogens)
• Inadequate treatment duration (though standard is 5 days minimum) 1
• Unaddressed predisposing factors that are perpetuating recurrence
• Misdiagnosis (could be necrotizing infection, abscess, or non-infectious mimicker)

Simply repeating cefalexin—which already failed once—is unlikely to succeed unless the clinical scenario has fundamentally changed.

What You Should Do Instead

1. Reassess for Severity and MRSA Risk Factors

The IDSA guidelines stratify cellulitis management by severity and MRSA risk 1:

• Mild nonpurulent cellulitis (no systemic signs): Anti-streptococcal coverage alone (cefalexin, penicillin)
• Moderate nonpurulent (systemic signs present): Consider adding MSSA coverage
• Severe nonpurulent (penetrating trauma, MRSA colonization, injection drug use, purulent drainage, or SIRS): Requires MRSA coverage with vancomycin, linezolid, daptomycin, or TMP-SMX 1

Key point: If this patient has any MRSA risk factors or systemic signs, cefalexin alone is inadequate regardless of whether it's a repeat course.

2. Rule Out Necrotizing Infection

The IDSA explicitly states that failure of apparently uncomplicated cellulitis to respond to antibiotics after a reasonable trial is a red flag for necrotizing fasciitis 1. Before prescribing any oral antibiotic, ensure there is no:

• Skin necrosis
• Crepitus or gas in tissues
• Profound toxicity or hypotension
• Pain out of proportion to exam findings

If any of these are present, this requires urgent surgical consultation, not another course of oral antibiotics.

3. Address Predisposing Factors Aggressively

Recurrent cellulitis is driven by underlying risk factors 1, 2, 3:

• Lymphedema or chronic leg edema: Elevation and compression therapy
• Venous insufficiency: Compression stockings
• Toe web intertrigo/tinea pedis: Treat aggressively with antifungals—this is a major portal of entry 1
• Obesity, diabetes, immunosuppression: Optimize medical management

The IDSA strongly recommends examining interdigital toe spaces and treating any fissuring, scaling, or maceration to eradicate colonization and reduce recurrence 1. This is often overlooked but critical.

4. Consider Alternative Antibiotics for Acute Treatment

If you need to treat the current episode and MRSA is suspected or the patient has failed standard therapy:

Oral options with MRSA coverage 4:

• TMP-SMX (1-2 double-strength tablets twice daily) PLUS a beta-lactam (amoxicillin or cefalexin) for streptococcal coverage
• Doxycycline (100 mg twice daily) PLUS a beta-lactam 5
• Linezolid (600 mg twice daily)—expensive but highly effective 4

If streptococcal cellulitis is still most likely (early constitutional symptoms like chills/fever before erythema onset suggest streptococcus 6):

• Penicillin VK (500 mg four times daily) is actually superior to cefalexin for streptococcal infections
• Ceftriaxone (if IV access available) has excellent efficacy and fewer GI side effects 7

5. Initiate Long-Term Prophylaxis

Given this is now a recurrent cellulitis case, prophylaxis should be strongly considered 8, 2, 3, 9:

Penicillin V 250 mg twice daily is the gold standard for prophylaxis and reduces recurrence risk significantly (NNT = 5) 9. A landmark RCT showed 22% recurrence with penicillin prophylaxis vs. 37% with placebo during the treatment period 9.

Alternative prophylaxis options:

• Cefalexin (for patients who cannot tolerate penicillin or have gram-negative risk factors) 10
• Erythromycin (if beta-lactam allergy, though resistance is increasing)

Duration: Typically 12 months, though benefit diminishes after stopping 9. Some patients with multiple risk factors may need indefinite prophylaxis 2.

6. Consider Decolonization if Staphylococcal

If MRSA or recurrent staphylococcal abscesses are suspected 1:

• Intranasal mupirocin twice daily for 5 days
• Chlorhexidine body washes daily
• Dilute bleach baths (¼-½ cup per full bath)
• Decontaminate personal items (towels, sheets, razors)

Evidence for this is weak but may help in selected cases 1.

Common Pitfalls to Avoid

• Don't assume all cellulitis is streptococcal: Community-acquired MRSA is increasingly common, especially with purulent drainage, injection drug use, or prior MRSA infection
• Don't ignore toe web disease: This is the most common modifiable risk factor and is frequently missed
• Don't treat cellulitis for too short a duration: Minimum 5 days, but extend if not improving 1
• Don't forget to culture if atypical: Blood cultures and tissue aspirates should be obtained if the patient has systemic signs, immunosuppression, or treatment failure 1

Bottom Line Algorithm

1. Assess severity and MRSA risk → If severe or MRSA risk present, use vancomycin/linezolid/TMP-SMX + beta-lactam
2. Rule out necrotizing infection → If suspected, urgent surgery
3. Treat acute episode with appropriate antibiotic (NOT cefalexin if already failed)
4. Aggressively manage predisposing factors (especially toe web disease, edema)
5. Start prophylaxis with penicillin V 250 mg twice daily for 12 months after acute treatment completes

Repeating cefalexin without addressing why it failed the first time is a recipe for continued treatment failure and potential complications.